期刊文献+

氯仿中毒36例临床表现与诊断分析 被引量:1

Clinical Manifestations and Diagnostic Analysis of 36 Patients with Chloroform Poisoning
暂未订购
导出
摘要 目的总结氯仿中毒患者的临床表现及诊断方法。方法回顾性分析1996~2006年收治的36例氯仿中毒患者的临床表现、实验室检查、诊断及中毒机制。结果36例患者氯仿接触史明确,临床表现复杂多样,其中肝功能受损占80.6%、中枢神经损害占60.8%、皮肤损伤占42.3%,其他系统器官也有不同程度受损表现,且与前三者合并存在。在实验室检查中83%的患者前清蛋白(PA)降低,70%ALT升高。结论临床诊断必须有明确的氯仿接触史、临床表现和可靠的实验室检查指标,且需排除其他疾病。氯仿中毒可致多个器官损害,临床表现可分为肝型、脑型、皮肤型和混合型,以肝型最多见,实验室检查中以PA较敏感。 Objective To summarize the clinical manifestations and diagnostic methods of patients with chloroform poisoning. Methods Data of 36 patients with chloroform poisoning hospitalized from1996 to 2006 was analyzed retrospectively, In terms of their clinical manifestations, laboratory examination, diagnosis and toxic mechanism. Results The patients with chloroform poisoning had their specific histories of chloroform contacts, and their clinical manifestations were complicated and diversified. There were 80. 6% of them with livers damaged, 60. 8% of them with center nerve systems injured, 42. 3% of them with skin impaired. Other organs were also harmed simultaneously with the aforementioned organs or tissues in different degrees. Laboratory examination indicates: 83% of the patients' prealbumin (PA) level was decreased, and 70% of the patients' ALT level was increased. Conclusion Clinical diagnosis must be provided with the specific histories of contacting chloroform, clinical manifestations and credible assistant check - ups, and must exclude other diseases. Chloroform poisoning could injure many human body's systems or organs, and they can be divided into liver -type, cerebral type, skin -type and mixed type. The liver - type is the commonest one, and the test of PA level is the most sensitive in laboratory examination.
出处 《中国全科医学》 CAS CSCD 2007年第10期823-824,共2页 Chinese General Practice
关键词 氯仿 中毒 病理状态 体征和症状 诊断 Chloroform Poisoning Pathological Conditions, Signs and Symptoms Oiagnosis
  • 相关文献

参考文献6

二级参考文献18

  • 1徐惟安,王敏,祝慧娟,黄幸纾.丝裂霉素C对小鼠早期精细胞的微核效应[J].浙江医科大学学报,1989,18(3):118-119. 被引量:20
  • 2杜宇欣.WHO饮用水水质准则[J].环境与健康,1996,2(1):101-102.
  • 3Davidson IWF, SumnerDD, Parker JC. Chioroform: a review of its metabolism, teratogenic, mutagenic, and carcinogenic potential[J]. Drug chem Toxicol, 1982,5(1) : 1 - 2.
  • 4Kristensen O. A prospective study of hand eczema in an automobile manufacturing industry[J]. Contact Dermatitis, 1992, 26(5) :341 - 342.
  • 5Grubauer G, Elias PM, Feingold KR. Transepidermal water loss: the signal for recovery of barrier structure and function [J].J Lipid Res, 1989,30:323- 324.
  • 6Beech JA. Estimated worst case trihalomethane body burden of child using a swimming pool [J]. Med Hypotheses,1980,193(6):3-4.
  • 7Denda M, Wood LC,Emami S, et al. The epidermal hyperplasia associated with repeated barrier disruption by actone treatment or tape stripping cannot be attributed to increased water loss[J]. Arch Dermatol Res, 1996,288(12) :230 - 232.
  • 8Menon GK, Feingold KR, Elias PM. l.amellar body secretory response to barrier disruption [J]. J Ivest Dermatol, 1992, 98(7) :279 - 280.
  • 9凌波,环境保护,1992年,1期
  • 10陈培康,给水净化新工艺,1990年

共引文献17

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部